Trial Profile
Value of Contrast-enhanced Ultrasonography and Magnetic Resonance Enterography to Predict the Efficacy of Anti-TNF Therapy in Crohn's Disease Complicated by Symptomatic Small Bowel Stricture
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Feb 2017
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms CREOLE
- 08 Feb 2017 New trial record
- 24 Jan 2017 Results published in the Gut